01-14-2019 04:47 PM CET - Health & Medicine
Print

Pulmonary Drugs Market Will Reach 49000 Million US$ in 2023, From 30400 Million in 2018

Press release from: ReportsandReports
Pulmonary Drugs Market
Pulmonary Drugs Market
“Global Pulmonary Drugs Market 2018” which highlights the Pulmonary Drugs Market size, comprehensive Pulmonary Drugs Industry dynamics and high-tech updates of global Pulmonary Drugs Market with respect to Pulmonary Drugs Industry opportunities, threats, challenges, constraints, cost structure and current trends in the Pulmonary Drugs Industry. This independent 135 Page report based on analysis over 10 Major Key Players guarantees you will remain better informed than your competition. The pulmonary drugs are used for treating the conditions affecting lungs. The pulmonary drugs are used from treating minor illnesses such as the common cold to cure long-term disorders such asthma.

Download Pulmonary Drugs Market Research (Sample) Copy: www.reportsnreports.com/contacts/requestsample.aspx?name=...

Report Covers Pulmonary Drugs Market Segment by Top Manufacturers are:

• Sanofi SA
• Meda Pharmaceuticals
• Circassia Pharmaceuticals Plc.
• AstraZeneca Plc.
• GlaxoSmithKline Plc.
• Mallinckrodt Pharmaceuticals Plc.
• Cheisi Farmaceutici S.p.A
• Zambon Company S.p.A
• Alaxia SAS
• Merck Sharp & Dohme Limited

These agents are available in different forms such as oral tablets, oral liquids, and injections or inhalations. Inhalations deliver the medicine directly to the lungs, which can act directly on the lung tissues, minimizing systemic side effects. The major factors driving growth of the pulmonary drugs market include increasing incidence of chronic respiratory diseases, tobacco smoking, and government and non-government initiatives. The worldwide market for Pulmonary Drugs is expected to grow at a CAGR of roughly 8.3% over the next five years, will reach 49000 million US$ in 2023, from 30400 million US$ in 2017, according to a new study.

Get Direct Access of This Report: www.reportsnreports.com/purchase.aspx?name=1625641

Pulmonary Drugs Market Segmentation based on the Product Types are:

- Inhaled Corticosteroids
- Long Acting Beta-2 Agonists
- Antihistamines
- Vasodilators
- Others

Pulmonary Drugs Market Segmentation based on the User Applications are:

- Asthma & COPD
- Allergic Rhinitis
- Pulmonary Arterial Hypertension
- Cystic Fibrosis
- Others

To understand Pulmonary Drugs Market dynamics in the world principally, the global Pulmonary Drugs Market is analyzed across key global regions. ReportsnReports also prepares customized separate regional and country-level Pulmonary Drugs reports for the following areas :-

North America: United States, Canada, and Mexico.
Central & South America: Brazil and Argentina.
Middle East & Africa: Saudi Arabia, and Turkey.
Europe: Germany, France, UK, Italy, Spain, and Russia.
Asia-Pacific: China, India, Japan, South Korea, Australia, Indonesia, and Singapore.

About Us:

ReportsnReports.com is your single source for all Market research needs. Our database includes 500,000+ Market research reports from over 95 leading global publishers & in-depth Market research studies of over 5000 micro Markets. With comprehensive information about the publishers and the industries for which they publish Market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Connect with us:
Vishal Kalra
+ 1 888 391 5441
sales@reportsandreports.com

This release was published on openPR.
News-ID: 1496069 • Views: 119
More releasesMore releases

You can edit or delete your press release here: